Fosigotifator (ABBV-CLS-7262)

About Calico

Calico (Calico Life Sciences LLC) is a pioneering, research-driven biotechnology company singularly focused on deciphering the biology of aging and translating those insights into novel therapeutics. Founded by Arthur D. Levinson and backed by Alphabet, it operates with a unique, long-term horizon, blending academic-style basic research in model organisms with industrial-scale drug discovery and development. Its pipeline includes several early- and clinical-stage assets targeting specific diseases of aging, supported by a robust technology platform and strategic collaborations with leading academic and industry partners.

Therapeutic Areas